
|Videos|April 21, 2022
Patient Quality of Life on Lenvatinib plus Pembrolizumab Treatment for Renal Cell Carcinoma
Oncologists review quality of life data for patients with renal cell carcinoma receiving lenvatinib plus pembrolizumab combination treatments.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Exploring The Application of Artificial Intelligence in Radiology Scans
2
Navigating the Surgical Nuances of Inflammatory Breast Cancer and Phyllodes Tumors
3
Indirect Comparison Supports Zanubrutinib Monotherapy in CLL/SLL Care
4
Adjuvant Chemo Noninferor at 3 Months Vs 6 Months in Stage II/III CRC
5














































